Clinical Trial Update: Bupropion for the Treatment of Methamphetamine Dependence - 1 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating bupropion for methamphetamine dependence, conducted by NIDA, has completed. No results are provided in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methamphetamine Use Disorder

Drugs mentioned

• bupropion (bupropion)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Amphetamine-Related Disorders | Phase 2 | Status: COMPLETED